Pharmaceuticals

A Japanese-led research team has developed AUN, a groundbreaking immune-independent bacterial cancer therapy that uses two harmonized bacteria to destroy tumors even in patients with weakened immune systems. By leveraging the natural synergy between Proteus mirabilis and Rhodopseudomonas palustris, AUN selectively targets cancer cells, reshapes itself within tumors, and avoids harmful side effects like cytokine release syndrome.

Millions struggle with depression and anxiety, often enduring long waits for effective treatment. Scientists in Sweden, Denmark, and Germany are developing a genetic test to predict which medications will actually work. Using polygenic risk scores, they can analyze DNA variations linked to mental health and drug response.

Scientists have pinpointed a “Big Bang” moment in bowel cancer—when cells first evade the immune system. This early immune escape locks in how the cancer will behave as it grows. The discovery could help predict which patients respond to immunotherapy and lead to new vaccine strategies

Scientists have discovered a surprising benefit of the acne drug doxycycline: it may lower the risk of schizophrenia. Teens prescribed the antibiotic were about one-third less likely to develop the condition as adults. The effect could stem from the drug’s ability to reduce brain inflammation. Researchers say the findings highlight an unexpected new direction in mental health prevention.

Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The pill also improved cardiovascular risk factors and physical activity levels. With a safety profile consistent with existing treatments, experts see it as a breakthrough for patients preferring oral options.

Researchers have, for the first time, estimated how quickly E. coli bacteria can spread between people — and one strain moves as fast as swine flu. Using genomic data from the UK and Norway, scientists modeled bacterial transmission rates and discovered key differences between strains. Their work offers a new way to monitor and control antibiotic-resistant bacteria in both communities and hospitals.

Long-term melatonin use for sleep problems may come with unexpected heart dangers. Researchers found that chronic users were almost twice as likely to die and 3.5 times more likely to be hospitalized for heart failure. Though melatonin is widely regarded as harmless, experts now urge caution with extended use.

Penn State scientists uncovered an ancient bacterial defense where dormant viral DNA helps bacteria fight new viral threats. The enzyme PinQ flips bacterial genes to create protective proteins that block infection. Understanding this mechanism could lead to breakthroughs in antivirals, antibiotic alternatives, and industrial microbiology.

Scientists have discovered that a “longevity gene” found in people who live beyond 100 can reverse heart aging in models of Progeria, a devastating disease that causes children to age rapidly. By introducing this supercentenarian gene into Progeria-affected cells and mice, researchers restored heart function, reduced tissue damage, and slowed aging symptoms. The discovery opens the door to new therapies inspired by the natural biology of long-lived humans—possibly reshaping how we treat both rare diseases and normal aging.

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who qualifies for the drug.

A team of scientists discovered a hidden antibiotic 100 times stronger than existing drugs against deadly superbugs like MRSA. The molecule had been overlooked for decades in a familiar bacterium. It shows no signs of resistance so far, offering hope in the fight against drug-resistant infections and paving the way for new approaches to antibiotic discovery.

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, nonspecific way, enhancing cancer treatment outcomes. If confirmed, the discovery could lead to a universal cancer vaccine and transform oncology care.

Colorado researchers discovered that nearly half of tested cannabis flower products exaggerated their THC levels, while concentrates were mostly accurate. The team’s statewide audit revealed potency inconsistencies that could mislead consumers and affect safe dosing. Beyond THC, the study also found that cannabinoids like CBG and CBGA are underreported. The findings may help shape future regulations and improve consumer trust in the growing cannabis market.

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 patients worldwide and was led by Cedars-Sinai researchers. Experts call it a game changer that’s likely to reshape treatment guidelines for aggressive prostate cancer.

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived dramatically longer than those who didn’t. Researchers from the University of Florida and MD Anderson Cancer Center discovered that the vaccine’s immune-activating properties may boost cancer-fighting responses, acting like a nonspecific “flare” that reawakens the immune system.

Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye complications for people with obesity and diabetes. Over 10 years, patients lost far more weight and required fewer medications. Experts say surgery continues to offer survival advantages even in the age of potent obesity drugs.

Salk Institute scientists discovered that bile acids in the liver can weaken immune cell function, making immunotherapy less effective against liver cancer. They pinpointed specific bile acids that suppress T cells and found that supplementing with UDCA reversed the effect, controlling tumor growth in mice. Since UDCA is already used for liver disease, it could quickly translate into clinical trials.

A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it accurately models how genetics influence drug reactions. The system replicated flucloxacillin-related toxicity seen only in people with a specific genetic variant, marking a major step toward predictive, patient-tailored drug safety testing.

Endurance exercise may train the immune system as much as the muscles. Older adults with decades of running or cycling had immune cells that functioned better and aged more slowly. Their inflammation levels were lower and their cells resisted fatigue even under stress. The findings point to a direct link between lifelong fitness and healthier immune regulation.

A team at Massachusetts General Hospital uncovered that an immune defense protein, Resistin-like molecule gamma, attacks heart cells after a heart attack—literally punching holes in them. This discovery explains why dangerous, fast heart rhythms can strike after an infarction. By removing this molecule in mice, the researchers reduced deadly arrhythmias twelvefold, suggesting that targeting immune-driven damage could open a new path to preventing sudden cardiac death.

Finasteride, a common hair-loss drug, has long been tied to depression and suicide, but regulators ignored the warnings. Prof. Mayer Brezis’s review exposes global data showing psychiatric harm and a pattern of inaction by Merck and the FDA. Despite its cosmetic use, the drug’s effects on brain chemistry can be devastating. Brezis calls for urgent regulatory reforms and post-marketing studies to protect public health.

Researchers at the University of Barcelona found that combining pemafibrate and telmisartan significantly reduces liver fat and cardiovascular risks in MASLD models. The drug duo works better together than alone, likely due to complementary mechanisms. They also uncovered a new role for the PCK1 protein in fat metabolism.

A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications. In a recent study, the drug lowered blood pressure and also seemed to protect the kidneys by reducing signs of damage. Doctors say this could help millions of people with chronic kidney disease, a condition that often makes blood pressure harder to control.

A new study shows glioblastoma isn’t confined to the brain—it erodes the skull and hijacks the immune system within skull marrow. The cancer opens channels that let inflammatory cells enter the brain, fueling its deadly progression. Even drugs meant to protect bones can make things worse, highlighting the need for therapies that target both brain and bone. The discovery reframes glioblastoma as a whole-body disease, not just a brain disorder.

Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it strengthens T-cell receptors, enhances immune signaling, and improves the effects of immunotherapy. Found naturally in foods like spinach and peppers, it’s safe, accessible, and now a promising candidate for cancer treatment trials.

Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes therapies more effective. Early mouse studies show strong potential for a new treatment approach.

Researchers have revealed how polymyxins, crucial last-resort antibiotics, break down bacterial armor by forcing cells to overproduce and shed it. Astonishingly, the drugs only kill bacteria when they’re active, leaving dormant cells untouched. This discovery could explain recurring infections and inspire strategies to wake bacteria up before treatment.

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by nearly half.

Daily cocoa extract supplements reduced key inflammation markers in older adults, pointing to a role in protecting the heart. The findings reinforce the value of flavanol-rich, plant-based foods for healthier aging.

Scientists have discovered a way to block pain while still allowing the body’s natural healing to take place. Current painkillers like ibuprofen and aspirin often come with harmful side effects because they shut down both pain and inflammation. But this new research identified a single “pain switch” receptor that can be turned off without interfering with inflammation, which actually helps the body recover.

A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike most GLP-1 agonists that require injections, orforglipron comes as a once-daily pill, potentially making weight-loss treatment more accessible.

Scientists have discovered that cancer uses a hidden hormone to switch off the body’s natural defenses, allowing tumors to grow unchecked. By uncovering this secret signal, they found a way to block it and restore the immune system’s ability to fight back. The breakthrough not only hints at powerful new cancer treatments but also suggests the same pathway could someday be used to calm autoimmune diseases.

Alcohol-associated liver disease is becoming a massive health and economic burden, but researchers at UC San Diego may have uncovered a new way forward. They discovered that chronic alcohol use blocks a crucial protein that normally helps keep gut bacteria from leaking into the liver, worsening damage. Restoring this protein’s function, using drugs already in development, could not only reduce liver disease but also have implications for treating alcohol addiction itself.

People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving. This new research hints the drug may offer freedom from the constant distraction of food noise.

Preschoolers with ADHD are often given medication right after diagnosis, against medical guidelines that recommend starting with behavioral therapy. Limited access to therapy and physician pressures drive early prescribing, despite risks and reduced effectiveness in young children.

Scientists discovered that a gut bacteria molecule called corisin can travel to the kidneys, triggering inflammation and scarring that lead to diabetic kidney fibrosis. By attaching to albumin in the blood, corisin infiltrates kidney tissue and accelerates damage. In animal studies, antibodies that neutralize corisin slowed disease progression, offering hope for new treatments beyond dialysis and transplants.

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial tested immunotherapy in resectable cases, with promising results presented at the World Conference on Lung Cancer.

Metformin, long trusted for diabetes, turns out to work in the brain too. By shutting down Rap1 in the hypothalamus, the drug lowers blood sugar more effectively than previously understood, opening doors for new therapies.

Scientists discovered seven molecules in the blood linked to excessive daytime sleepiness, a condition that affects one in three Americans and raises the risk of heart disease, obesity, and diabetes. The study highlights the role of both diet and hormones, finding that omega-3 and omega-6 fatty acids may protect against drowsiness, while compounds like tyramine may worsen it.

Sucralose, the sugar substitute in many diet products, may weaken cancer immunotherapy by altering gut bacteria and reducing arginine levels needed for immune cells. But supplementation with arginine or citrulline could counteract this effect, pointing to new clinical trial possibilities.

Drinking nitrate-rich beetroot juice lowered blood pressure in older adults by reshaping their oral microbiome, according to researchers at the University of Exeter. The study found that beneficial bacteria increased while harmful ones decreased, leading to better conversion of dietary nitrates into nitric oxide—a molecule vital for vascular health.

Harvard scientists have uncovered that lithium, a naturally occurring element in the brain, may be the missing piece in understanding Alzheimer’s. Their decade-long research shows that lithium depletion—caused by amyloid plaques binding to it—triggers early brain changes that lead to memory loss. By testing new lithium compounds that evade plaque capture, they reversed Alzheimer’s-like damage and restored memory in mice at doses far lower than those used in psychiatric treatments.

For people with macular telangiectasia type 2 (MacTel), an orphan retinal disorder that gradually destroys central vision, there have long been no approved treatment options. But now, a new study sponsored by Neurotech Pharmaceuticals and spearheaded by investigators at Scripps Research and the National Institutes of Health offers compelling evidence that vision loss can be slowed with a neuroprotective surgical implant.

Painkillers we often trust — ibuprofen and acetaminophen — may be quietly accelerating one of the world’s greatest health crises: antibiotic resistance. Researchers discovered that these drugs not only fuel bacterial resistance on their own but make it far worse when combined with antibiotics. The findings are especially troubling for aged care settings, where residents commonly take multiple medications, creating perfect conditions for resistant bacteria to thrive.

Researchers uncovered that hypothalamic neurons safeguard blood sugar overnight by directing fat breakdown, preventing hypoglycemia during early sleep. This subtle control system may explain abnormal metabolism in prediabetes.

Researchers have created plant-based microbeads that trap fat in the gut, helping rats lose weight without side effects. Unlike current drugs, the beads are safe, tasteless, and easy to mix into everyday foods. Human trials are now underway.

Scientists have engineered a groundbreaking cancer treatment that uses bacteria to smuggle viruses directly into tumors, bypassing the immune system and delivering a powerful one-two punch against cancer cells. The bacteria act like Trojan horses, carrying viral payloads to cancer’s core, where the virus can spread and destroy malignant cells. Built-in safety features ensure the virus can’t multiply outside the tumor, offering a promising pathway for safe, targeted therapy.

A groundbreaking study has found that a simple change in walking style can ease osteoarthritis pain as effectively as medication—without the side effects. By adjusting foot angle, participants reduced knee stress, slowed cartilage damage, and maintained the change for over a year.

Arizona State University scientists have unveiled NasRED, a revolutionary one-drop blood test that can detect diseases like COVID-19, Ebola, HIV, and Lyme with incredible speed and precision. Using gold nanoparticles to spot microscopic disease markers, the device delivers results in just 15 minutes—outperforming traditional lab tests in sensitivity, speed, and affordability. Portable and costing only $2 per test, it could be deployed from remote clinics to urban hospitals, offering a lifeline for early detection and outbreak control worldwide.

Stopping prescription weight loss drugs often leads to significant weight regain, according to a large-scale analysis of 11 global studies. Researchers found that although these medications, including GLP-1-based treatments like semaglutide and tirzepatide, help patients lose substantial weight while in use, gains tend to return within weeks of stopping.

In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered that some FDA-approved cancer medications could reverse damage caused by Alzheimer's.

A mysterious gut hormone may be behind many cases of chronic diarrhea, especially in people with undiagnosed bile acid malabsorption, a condition often mistaken for irritable bowel syndrome. Researchers from the University of Cambridge identified that the hormone INSL5 spikes when bile acid reaches the colon, triggering intense diarrhea. Their discovery not only sheds light on the biological cause of symptoms but opens the door to a diagnostic blood test and new treatment options, including a surprising existing drug that blocks this hormone’s effects.

A team of scientists has developed a remarkable new approach to modeling how cells behave over time—using a digital "forecast" much like predicting the weather. By combining patient genomics with a groundbreaking plain-language “hypothesis grammar,” the researchers can simulate how cells communicate and evolve within tissues. These simulations allow scientists to digitally test how cancers grow, how immune systems respond, and even how treatments might work in individual patients.

A virus from humble black-eyed peas is showing extraordinary promise in the fight against cancer. Unlike other plant viruses, the cowpea mosaic virus (CPMV) can awaken the human immune system and transform it into a cancer-fighting powerhouse, without infecting human cells. By comparing it to a similar, but ineffective, virus, researchers uncovered that CPMV uniquely triggers potent interferons and immune responses, making it a low-cost, plant-grown immunotherapy on the fast track toward clinical trials.

A massive global survey has revealed that people with eating disorders often turn to cannabis and psychedelics like magic mushrooms and LSD to ease their symptoms, rating them more effective than traditional medications. Surprisingly, common prescriptions like antidepressants were seen as helpful for overall mental health but fell short for eating disorder relief.

Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with immunotherapy can transform stubborn, unresponsive lung tumors into targets for immune attack—especially those considered “cold” and typically resistant. This happens through a rare and poorly understood effect where immune cells are activated systemically, not just at the radiation site. Patients whose tumors underwent this “warm-up” had significantly better outcomes, revealing a promising new strategy for fighting hard-to-treat cancers.

Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian scientists have joined this biomedical frontier by creating bacteria-killing proteins with AI. Their new platform, built by a team of biologists and computer scientists, is part of a global movement to democratize and accelerate protein design for medical breakthroughs.

In a remarkable twist of science, researchers have transformed a fungus long associated with death into a potential weapon against cancer. Found in tombs like that of King Tut, Aspergillus flavus was once feared for its deadly spores. Now, scientists at Penn and several partner institutions have extracted a new class of molecules from it—called asperigimycins—that show powerful effects against leukemia cells. These compounds, part of a rare group known as fungal RiPPs, were bioengineered for potency and appear to disrupt cancer cell division with high specificity.

Colistin, a last-resort antibiotic, is losing its power due to rising resistance—and the culprits might be hiding in your seafood dinner. A University of Georgia research team discovered colistin-resistance genes in bacteria found in imported shrimp and scallops from markets in Atlanta. These genes can hop between bacteria via plasmids, potentially turning once-curable infections into deadly threats.

Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data discrepancies, missing lab readings, and questions about the integrity of the trial process. Notably, key results reported in a major cardiology journal were inaccurately presented, and some study contributors were omitted or denied involvement. With generics on the horizon, critics say these revelations highlight potential dangers, including severe rebound effects and bleeding risks, that were never properly disclosed.